載入...
The successful use of dronabinol for failure to thrive secondary to intestinal dysmotility
INTRODUCTION: Symptoms of severe intestinal dysmotility decrease patients’ quality of life and may prevent them from sustaining adequate oral intake. Dronabinol is a synthetic cannabinoid that is labeled for use in AIDS-related anorexia and chemotherapy-associated nausea and vomiting that has additi...
Na minha lista:
| 發表在: | Int J Surg Case Rep |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4446691/ https://ncbi.nlm.nih.gov/pubmed/25974259 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijscr.2015.04.036 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|